Yale School of Medicine

News and Video Search Results

News coverage

Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients

GlobeNewswire 16 May 2024

CHICAGO, May 16, 2024 (GLOBE NEWSWIRE) -- Today, the Foundation for Sarcoidosis Research (FSR), the leading international..

Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors
GlobeNewswire 15 May 2024
Ipsen appoints Keira Driansky as EVP, President of North America
GlobeNewswire 02 May 2024
IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
GlobeNewswire 02 May 2024
The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 18 Apr 2024

0 shares 1 views

You might like

Yale School of Medicine media coverage

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”

GlobeNewswire 09 Apr 2024

Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary..

Notice convening the Annual General Meeting in BioPorto A/S
GlobeNewswire 04 Apr 2024
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire 02 Apr 2024
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
GlobeNewswire 01 Apr 2024
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
GlobeNewswire 28 Mar 2024

Advertisement

More coverage

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

GlobeNewswire 13 Mar 2024

Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or..